Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion type Assertion NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_head.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_provenance.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion evidence source_evidence_literature NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_provenance.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion SIO_000772 20830770 NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_provenance.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion wasDerivedFrom befree-20140225 NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_provenance.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion wasGeneratedBy ECO_0000203 NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_provenance.